Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Amyloidosis Cardiac: later-stage trial registry
3 of 3 indexed Amyloidosis Cardiac trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Amyloidosis Cardiac: 3 US clinical trials tracked, 3 recruiting.
Amyloidosis Cardiac is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 1 of these trials.
Enrollment posture brief
Registry condition amyloidosis-cardiac
OPEN 3 | RECR 100% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Amyloidosis Cardiac lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Amyloidosis Cardiac on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Amyloidosis Cardiac is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
University of Texas Southwestern Medical Center
NCT05489549
Intracardiac Flow Assessment in Cardiac Amyloidosis
Mayo Clinic
NCT05379101
Ultrasound Therapy In Cardiac Amyloidosis
Brigham and Women's Hospital
NCT04667494
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Amyloidosis Cardiac records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Amyloidosis Cardiac trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Amyloidosis Cardiac page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Amyloidosis Cardiac trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Brigham and Women's Hospital sponsors the most Amyloidosis Cardiac trials on record, review their full trial history before evaluating a specific study. See Brigham and Women's Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Amyloidosis Cardiac condition card totals 3 registered trials; most-linked intervention Six-minute Walk Test; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.